Speech Therapy and Repetitive Transcranial Magnetic Stimulation Therapy in Post-stroke Anomic Aphasia
Aphasia, Aphasia, Anomic, Stroke
About this trial
This is an interventional treatment trial for Aphasia
Eligibility Criteria
Inclusion Criteria:
- Stroke diagnosed with cranial MR examination causing unilateral hemiplegia
- Post-stroke patients with anomic aphasia
- 40-70 years
- Being able to read the basic instructions
- Medically and neurologically stable patients
Exclusion Criteria:
- Clinical condition that will constitute a contraindication to TMS (metallic implant, Cardiac pacemaker, pregnancy, breastfeeding, epilepsy, head trauma...)
- Having previously had TMS treatment
- Presence of Life-threatening disease and/or active systemic disease (chronic disease, malignancy ...)
- Alcohol or drug addiction
- Presence of neurodegenerative or psychiatric disorders
- Pregnancy or breastfeeding status
- Severe cognitive impairment
- Having a history of previous epilepsy
- Visual and auditory impairment
Sites / Locations
- Ege University Faculty of Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Study group
Control group
After randomization, this group will take 10 sessions of 1-Hz low frequency rTMS will be applied to the inferior frontal gyrus of the right frontal lobe for 20 minutes during the stroke treatment process before 10 days of speech therapy. Speech therapy will be given to each patient by the same therapist who is qualified in this field, and the treatment will last 10 days, 60 minutes a day.
This group will take 10 sessions of sham rTMS for 20 minutes during the stroke treatment process before 10 days of speech therapy. The sham therapy will consist of positioning the coil on the cranium at the same spot, but without a magnetic stimulation, only with the device open and the sounds will be audible. Speech therapy will be given to each patient by the same therapist who is qualified in this field, and the treatment will last 10 days, 60 minutes a day.